Raised circulating corticosterone inhibits neuronal differentiation of progenitor cells in the adult hippocampus  by Wong, E.Y.H. & Herbert, J.
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OAISED CIRCULATING CORTICOSTERONE INHIBITS NEURONAL
IFFERENTIATION OF PROGENITOR CELLS IN THE
DULT HIPPOCAMPUS
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bstract—Neurons are added throughout life to the dentate
yrus of the hippocampus of the mammalian brain. Progen-
tors residing in the dentate gyrus progress through three
istinct stages of adult neurogenesis: proliferation, survival
nd differentiation. One of the most potent factors which
egulates adult neurogenesis is adrenal-derived glucocorti-
oids. Raised levels of glucocorticoids suppress progenitor
ivision, while removal of glucocorticoids by adrenalectomy
timulates proliferation of these cells in the dentate gyrus.
e have recently reported that both pre- and post-mitotic
orticoid environments powerfully regulate survival of pro-
enitor cells in a time-dependent manner. However, it is un-
nown if glucocorticoids alter the process of neuronal differ-
ntiation, since not all of the newly-formed cells acquire a
euronal fate during development. Here we employ triple
mmuno-fluorescence staining techniques to phenotype sur-
iving progenitor cells 28 days after labeling. Results show
hat high levels of corticosterone (the major glucocorticoid in
odents) either before or after progenitor labeling discour-
ged the acquisition of neuronal fate. Similar to its effect on
urvival, post-mitotic corticosterone also regulates neuronal
ifferentiation in a time-dependent fashion, but this action is
ost prominent from around 19–27 days after the cells were
orn. In contrast, a corticoid-free environment either before
r after progenitor proliferation did not affect neuronal differ-
ntiation. Combining these data with previous survival data
btained from the same animals allowed us to estimate the total
umber of neurons formed resulting from different corticoid
reatments. Raised corticosterone significantly reduced neuro-
al production while adrenalectomy resulted in significantly
igher number of neurons in the adult male rat hippocampus.
2005 Published by Elsevier Ltd on behalf of IBRO.
ey words: neurogenesis, differentiation, dentate gyrus, hip-
ocampus, cortico steroids, progenitor cells.
eurogenesis in the adult brain is now well established
ince its first report 40 years ago (Altman and Das, 1966).
wo regions, the subventricular zone and the dentate
yrus of the hippocampus, are known to produce new
eurons throughout life (Cameron et al., 1993; Corotto et
l., 1993). Neuron formation during adulthood occurs in
iverse species including rodents (Cameron et al., 1993),
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pen access under CC BY license.h
bbreviations: ADX, adrenalectomy/adrenalectomized; DCX, dou-
lecortin.
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Open access undonkeys (Gould et al., 1999b) and humans (Eriksson et
l., 1998). The hippocampus is a structure involved in mem-
ry formation (Izquierdo and Medina, 1997), consolidation
Nadel and Moscovitch, 1997) and retrieval (de Quervain
t al., 2000), and such functions have raised the possibility
hat constitutively produced new neurons may play crucial
oles in learning and memory (Kempermann, 2002). Since
rugs known to be effective antidepressants stimulate neu-
ogenesis (Santarelli et al., 2003), there is recent clinical
nterest in the possibility that either the onset of depression
r its treatment may be associated with changes in neuro-
enesis in the dentate gyrus (Sapolsky, 2004; Malberg and
chechter, 2005).
A wide range of factors has been shown to regulate
dult neurogenesis. Learning (Gould et al., 1999a), expe-
ience (Kempermann et al., 1997), neural injuries (Liu et
l., 1998; Haughey et al., 2002) and growth factors (Kuhn
t al., 1997; Aberg et al., 2000) stimulate neurogenesis
hile ageing (Kuhn et al., 1996), psychological/physical
tress (Gould et al., 1997; Pham et al., 2003), radiation
Peissner et al., 1999), alcohol (Nixon and Crews, 2002)
nd many others suppress this process.
The fate of progenitors in the dentate gyrus can be
lassified into three distinct stages: proliferation, survival
nd differentiation. Progenitor cells divide and give rise to
aughter cells which form clusters at the subgranular zone
f the dentate gyrus. A proportion of these newly-formed
ells undergo apoptosis and only about half of them sur-
ive (Wong and Herbert, 2004). The surviving progenitors
hen differentiate into neurons, glia and other cell types
Monje et al., 2002). Modulators of neurogenesis may
ffect a particular developmental stage (Kempermann et
l., 1997), and therefore it is important to study the three
tages separately in order to understand how the produc-
ion of neurons is regulated in the adult brain.
Glucocorticoids (cortisol in humans, or corticosterone in
odents) are adrenal-derived steroids. Glucocorticoids enter
he brain through the blood–brain barrier, and their levels are
eightened during stressful events. Raised levels of glu-
ocorticoids suppress proliferation of progenitor cells in the
entate gyrus, while removal of glucocorticoids by adrenal-
ctomy (ADX) stimulates this process (Gould et al., 1992;
ameron and Gould, 1994). In our recent report (Wong and
erbert, 2004), we demonstrated that in addition to glucocor-
icoids’ effects on proliferation, raised levels reduced survival
f newly-formed cells and a glucocorticoid-free environment
romoted survival of these cells. However, whether glucocor-
icoids regulate differentiation of progenitor cells in the adult
ippocampus has not been studied.
er CC BY license.
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E. Y. H. Wong and J. Herbert / Neuroscience 137 (2006) 83–9284EXPERIMENTAL PROCEDURES
nimals
ll procedures were carried out under Home Office (UK) license
nd guidelines. These stipulate the minimal use of animals and
rocedures required to minimize pain and suffering. Lister
ig. 1. The morphology of (a) a BrdU/DCX double positive cell, (b) a B
f experiment 1. (e) The percentage of phenotypes of BrdU-labeled c
rdU cells positive for the immature neuronal marker DCX at this time-
orticosterone treatment significantly reduced the percentage of BrdU cell
g) The phenotype of BrdU-labeled cells at day 28. Corticosterone did no
ew neurons produced at day 28 calculated using the equation desc
ignificantly reduced the number of new neurons produced in the dentate gyruooded male rats (Harlan, Bicester, UK), weighing around
50–300 g at the beginning of the experiment, were used. Rats
ere housed three–four per cage on reversed 12-h light/dark
ycles (lights off at 11:00 h). Ambient temperature was main-
ained at 21°2 °C. Food and water were available ad libitum.
ll surgeries were carried out under general anesthesia. ADX
double positive cell, (c) a BrdU/GFAP double positive cell. (d) Design
y 7. Corticosterone treatment significantly reduced the percentage of
1,116.40, P0.03). (f) The phenotype of BrdU-labeled cells at day 28.
or themature neuronal marker NeuN at day 28 (§ F1,1131.9,P0.0001).
e proportion of BrdU cells expressing DCX at day 28. (h) The number of
xperimental Procedures (data in Table 1). Corticosterone treatmentrdU/NeuN
ells at da
point (§ F
positive f
t affect th
ribed in Es 28 days after BrdU labeling (§ F1,1114.4, P0.004).
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E. Y. H. Wong and J. Herbert / Neuroscience 137 (2006) 83–92 85nimals were given a choice of 0.9% saline and water to
eplenish salt loss.
rdU injection and corticosterone
evel manipulations
-bromodeoxyuridine (BrdU) (Sigma), a thymidine analog incor-
orated into dividing cells during DNA synthetic phase (S-phase)
f the cell cycle, was dissolved in 0.9% saline and injected i.p.
200 mg/kg) at midday. A single BrdU injection paradigm was
hosen to ensure that the population of cells labeled would come
rom the same time frame, and thus all newborn cells are in the
ame developmental phase at the start of the drug treatment.
To remove circulating glucocorticoids, bilateral ADX was per-
ormed under isoflurane anesthesia. Basal levels of corticosterone
ere replaced with s.c. implants of 1:1 corticosterone/cholesterol
Sigma) melted and molded into pellets weighing 200–220 mg. To
ncrease plasma corticosterone above ‘basal’ levels, animals were
iven additional s.c. injections of corticosterone suspended in peanut
il at 40 mg/kg/day, a dose shown to reduce neurogenesis. Refer-
nce plasma corticosterone levels of these different paradigms can
e obtained in our recent publication (Wong and Herbert, 2005).
xperimental procedures
Experiment 1. Thirty animals, given a single injection of
rdU, were divided into three groups. Group 1 (n6) was killed
4 h after the BrdU injection. Group 2 (n12) received a daily
njection of peanut oil, beginning 24 h after BrdU. Group 3 (n12)
eceived 40 mg/kg/day corticosterone suspended in peanut oil.
nimals (n6) from each treatment group (2 and 3) were sampled
t seven and 28 days after BrdU (Fig. 1d).
Experiment 2. Fifty-six intact rats were given BrdU as
bove, and then received various regimens of daily s.c. injections
f either corticosterone (40 mg/kg/day) or oil for 27 days. They
ere divided into seven groups of eight rats each. Group 1
eceived oil throughout. The next three groups received corti-
osterone for 9 days each, or oil otherwise. The start of corti-
osterone was staggered by nine days in each group (group
wo days 1–9, group three days 10–18, group four days 19–
7). Group five received CORT on days 1–18, group six days
0–27, and group seven days 1–27. All rats were killed on day
8 (Fig. 2a).
Experiment 3. Rats were divided into two major groups
n24 each). The first group was given daily oil injections for 10
ays (pre-treatment), and then two injections of BrdU, 3 h apart,
n day 10. This double injection protocol served to label a
arger pool of proliferating cells to compensate for the suppres-
ive effect of corticosterone on cell division. The second group
n24) was given daily injections of corticosterone (40 mg/kg/
ay) for 10 days, and BrdU as above. Each group was then
ivided into three sub-groups. Groups 1a and 2a were killed
4 h after the BrdU injection. Groups 1b and 2b were given
nother 28 days (post-treatment) of oil injections. Groups 1c
nd 2c were given 28 days of corticosterone (40 mg/kg/day).
he latter four sub-groups were perfused 24 h after the last
njection (day 29) (Fig. 3a).
Experiment 4. Four groups of animals were used in this
xperiment (n56). They all received a single injection of BrdU
200 mg/kg, i.p.) to label the new-born cells. In group 1 (n8),
nimals were killed 24 h after BrdU labeling, whereas in group 2
n16) they were sham-operated 24 h after BrdU and implanted
.c. with a cholesterol pellet. Eight rats were perfused at seven
nd 28 days after surgery. Group 3 (n16) was bilaterally ADX
4 h after BrdU and implanted with a cholesterol pellet. Rats (n8)
ere sampled at the same intervals. Group four (n16) were also tDX, but received a 50% corticosterone pellet (200–250 mg).
hey were sampled at the same intervals (Fig. 4a).
Experiment 5. All rats were adrenalectomized (ADX)
n48), half were given basal corticosterone replacement (s.c.
mplant of 50% corticosterone pellet) and the others received a
holesterol pellet. Ten days after surgery, all animals received a
ingle injection of BrdU. Each of the two original groups was
ivided into three sub-groups. The first two sub-groups (1a, 2a:
8 per group) were killed 24 h after the BrdU injection. The
econd sub-groups (1b, 2b: n8) had their corticosterone or
holesterol pellets removed and replaced with new, corticosterone
ellet 24 h after BrdU. The third sub-groups (1c, 2c; n8) had their
orticosterone or cholesterol pellets removed and replaced with
holesterol pellets. Sub-groups b and c were perfused 29 days
fter BrdU (Fig. 5a).
luorescence immunochemistry
nimals were given an overdose of pentobarbitone sodium and
erfused transcardially with 0.1 M PB followed by 4% paraformal-
ehyde in 0.01 M KPBS (pH 7.4). Brains were removed, post-fixed
or 4 h, and then immersed in 20% sucrose in KPBS overnight for
ryoprotection against formation of water ice crystals during
reezing. Coronal sections were cut using a freezing microtome
hrough the entire dentate gyrus at 40 m and sections were
tored in anti-freeze (1:1:2 glycerol:ethyleneglycol:0.1 M PBS).
ll rinses were done in 0.01 M KPBS. Sections were first
ncubated in 2 N HCl at 37 °C, and incubated overnight at room
emperature with rat anti-BrdU antibody (1:200, Accurate, USA) in
.2% Triton-X (Sigma, UK) and 5% normal goat serum (Vector
aboratories, USA). The sections were rinsed, and incubated in
odamine-RX conjugated anti-rat secondary antibodies (1:800;
ackson Laboratories, USA) for 60 min. Antibodies against dou-
lecortin (DCX; marker for immature neuron; mouse; 1:500, Santa
ruz Biotechnology, USA), NeuN (marker for mature neuron;
ouse; 1:800; Chemicon, USA) and GFAP (glial marker; rabbit;
:200; Sigma) were applied in combination depending on the
ime-point examined and incubated overnight at room tempera-
ure. Alexa-488 conjugated anti-mouse (1:500; Molecular Probes,
SA) or Alexa-647 conjugated anti-rabbit antibodies (1:500; Mo-
ecular Probes) were used in according to the primaries used.
ections were then mounted on to polylysine-coated slides and
overslipped with Vectamount (Vector Laboratories).
henotype determination
ll slides were randomized and coded prior to phenotype analysis.
nalysis was performed using a Zeiss Axioskop 2 fluorescence
icroscope (Zeiss, Germany). A 10-layer Z-stack (0.762 m
part) with images from each color channel was captured with a
4-bit black/white digital camera using a 40 objective. Z-stacks
ere then deconvolved using Zeiss deconvolution software (a math-
matical reconstruction model) to remove haze from adjacent
ections. At least 30 BrdU cells from each brain were analyzed.
ercentage neuronal differentiation was obtained from dividing
he number of cells positive for neuronal marker by total number of
ells analyzed.
stimation of total number of new
eu-N-stained neurons
he total number of new neurons in the sections examined was
stimated using the following equation:
NEstN0%Sur%Diff
here N represents the total number of new neurons; N refersEst 0
o the number of cells labeled by BrdU 24 h after labeling; %Sur is
F
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E. Y. H. Wong and J. Herbert / Neuroscience 137 (2006) 83–9286ig. 2. (a) Diagram depicting phased (9 days) corticosterone treatment for the seven groups over 27 days. (b) Corticosterone during period 3
ignificantly reduced neuronal differentiation († F1,156.8, P0.02), but not 1 or 2 alone. Giving corticosterone for 18 days or more significantly reduced
roliferation (123: § F1,1544.3, P0.0001; 12:
‡ F1,159.62, P0.008; 23:
 F1,1512.4, P0.008). (c) Corticosterone treatment for 18 days
† ‡r more (12 or 23 or 123) significantly reduced the numbers of new neurons 27 days after BrdU labeling (12: P0.001; 23: P0.002;
23: § P0.0001).
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E. Y. H. Wong and J. Herbert / Neuroscience 137 (2006) 83–92 87he number of surviving BrdU cells expressed as percentage of
ean BrdU cell count 24 h after labeling presented in our previous
eport (Wong and Herbert, 2004) and summarized in Table 1; %Diff
epresents the percentage of BrdU cells positive for the mature
euronal marker NeuN. The number of new neurons in the brain
ections sampled for a particular animal was calculated using the
ig. 3. (a) Diagram showing the treatment paradigm for the six
roups. (b) Both pre-mitotic and post-mitotic corticosterone signifi-
antly reduced neuronal differentiation (pre-mitotic: § P0.045; post-
itotic: † P0.0001; ‡ P0.001). (c) Both pre-mitotic and post-mitotic
orticosterone treatments significantly reduced the number of new
eurons formed 28 days after BrdU-labeling (§ P0.0001, † P0.0001,
P0.0001). Treating animals with corticosterone before BrdU re-
ulted in fewer new neurons than treating with corticosterone after
rdU (CORT/Oil vs Oil/CORT: § P0.021).orresponding survival and differentiation percentages. statistical analysis
ata were analyzed by one, two or three-way ANOVA; all data
resented as percentages were arcsine transformed before sta-
istical analysis. Instances in which non-parametric tests were
sed are specified in the results section.
RESULTS
xperiment 1: post-mitotic corticosterone reduced
euronal differentiation
ections from animals killed on day-7 post-BrdU were
riple-stained for BrdU, DCX and GFAP. A BrdU/DCX dou-
le positive cell is shown in Fig. 1a. Fig. 1e shows that
orticosterone treatment for 7 days significantly reduced
he percentage of BrdU cells immuno-positive for DCX at
his time point (one-way ANOVA; F1,116.04, P0.03).
orticosterone had no effect on differentiation into GFAP-
tained cells (GFAP: F1,110.06, P0.82). BrdU/NeuN
nd BrdU/GFAP cells are shown in Fig. 1b and c, re-
pectively. Corticosterone also significantly reduced the
ercentage of BrdU cells immuno-positive for NeuN
F1,1130.8, P0.0001, Fig. 1f) and GFAP (F1,115.54,
0.043) at day 28. To reveal whether this represented a
elay in maturation, day 28 sections were triple-stained for
rdU/DCX/GFAP. There was no difference in percentage
f BrdU-stained cells immuno-positive for DCX or GFAP or
hose staining for neither after corticosterone treatment
DCX: F1,111.43, P0.26; GFAP: F1,110.14, P0.72;
either: F1,112.15, P0.18) (Fig. 1g). Combining the sur-
ival data in Table 1 and these data showed that the total
umber of new neurons was reduced by corticosterone
reatment for 28 days (F1,1114.4, P0.004).
xperiment 2: time-dependency of the effect
f corticosterone on neuronal differentiation
rain sections from all seven groups were triple stained for
rdU/NeuN/GFAP. Fig. 2b shows the phenotypes of the
rdU-positive cells by percentage for each group. Three-
ay ANOVA, with each period as the independent variable,
howed that all three corticosterone treatment periods altered
he phenotypes of the BrdU-stained cells (0–9: F2,555.51,
0.023; 10–18: F2,555.74, P0.021; 19–27: F2,5515.9,
0.0001), and that there was no interaction between the
hree treatment periods.
As expected from experiment 1, animals receiving 27
ays of corticosterone had significantly lower percentage
f NeuN positive BrdU-stained cells compared with animals
eceiving oil (one-way ANOVA, F1,1543.6, P0.0001).
ne-way ANOVA also revealed that corticosterone treat-
ent during period 1 or 2 alone had no effect on the
ercentage of BrdU-stained cells expressing NeuN relative
o the Oil group (1: F1,150.93, P0.35; 2: F1,154.00,
0.07). However, treatment during period 3 alone signif-
cantly reduced this percentage (F1,156.81, P0.02). Al-
hough corticosterone treatment during period 1 or 2 had
o significant effect on the phenotype of BrdU cells, when
nimals were treated with corticosterone during both peri-
ds 1 and 2, the percentage of BrdU/NeuN cells was
ignificantly lowered (F1,159.43, P0.009). This is also
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E. Y. H. Wong and J. Herbert / Neuroscience 137 (2006) 83–9288rue of those receiving corticosterone during both periods 2
nd 3 (F1,1512.8, P0.003). There was no detectable
ifference in GFAP phenotype (1: F2,550.24, P0.88; 2:
2,550.34, P0.57; 3: F2,550.021, P0.89), and thus
he proportion of BrdU-stained cells also immuno-reactive
or NeuN correlates negatively with those that express
either NeuN nor GFAP.
The total numbers of new neurons being formed in
he different treatment groups are shown in Fig. 2c.
ne-way ANOVA and post hoc comparisons of the
even groups showed that the none of the single 9-day
orticosterone treatment had an effect (Bonferroni; 1:
1.00; 2: P1.00; 3: P1.00), but both the 18-day and
7-day corticosterone treatments significantly reduced
euronal production (12: P0.001; 23: P0.002;
23: P0.0001).
xperiment 3: effect of high levels of corticosterone
rior to progenitor proliferation on
euronal differentiation
n this experiment, animals received CORT either before or
fter BrdU labeling, or during both periods (see Fig. 3a).
he percentages of each cell type for each group are
hown in Fig. 3b. Corticosterone given both pre- and post-
rdU reduced NeuN phenotype. (Pre-treatment: F1, 319.73,
0.005; F 56.88, P0.0001.) One-way ANOVA of
ig. 4. (a) Diagram showing the corticoid manipulations in the diffe
ifferentiation of the newly-formed cells as detected by DCX, NeuN and
hat ADX significantly increased the number of new neurons formed i1,31
he four groups demonstrated that corticosterone treat- Cent significantly affected the percentage of BrdU-stained
ells expressing NeuN (F3,3124.8, P0.0001) but did not
lter the proportion of cells immuno-positive for GFAP
F3,310.52, P0.67). Post hoc pair-wise comparisons
howed that corticosterone pre-treatment reduced the per-
entage of BrdU/NeuN cells (Oil/Oil vs CORT/Oil; Bonfer-
oni, P0.041). Post-treatment with corticosterone irre-
pective of the pre-treatment significantly reduced the
rdU/NeuN percentage (Bonferroni, Oil/Oil vs Oil/CORT,
P0.0001; CORT/Oil Vs CORT/CORT, ‡ P0.002).
here was no significant difference between the Oil/CORT
nd CORT/CORT groups (P1.00). Importantly, the effect
f post-mitotic corticosterone on neuronal differentiation
as more pronounced than that of pre-mitotic treatment
orticosterone (Oil/CORT vs CORT/Oil: P0.040).
The total numbers of neurons generated from the
our different paradigms are shown in Fig. 3c. Two-way
NOVA showed that corticosterone, both pre-treatment
nd post-treatment, significantly affected neuronal pro-
uction (pre-treatment: F3,31114.6, P0.0001, post-
reatment: F3,3162.0, P0.0001). There was an inter-
ction between the two treatments (F3,3140.9, P
.0001). Post hoc analysis showed that animals
eceiving corticosterone treatment, whether before or
fter BrdU injection, had significantly fewer new neurons
Oil/CORT; P0.0001; CORT/Oil: P0.0001; CORT/
ups of animals. (b, c) There was no observable effect by ADX on
t day 7 and day 28. (d) Combining the survival data (Table 1) revealed
tate gyrus 28 days after BrdU labeling (§ P0.025).rent groORT: P0.0001). Treating animals with corticosterone
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E. Y. H. Wong and J. Herbert / Neuroscience 137 (2006) 83–92 89efore BrdU resulted in fewer new neurons than treat-
ent with corticosterone after BrdU (CORT/Oil vs Oil/
ig. 5. (a) Diagram depicting treatment paradigm for the six groups of
ats. (b) Graph showing phenotype of BrdU cells at day 28. There was
o difference in differentiation between the four day-28 treatment
roups. (c) Combining the neuronal differentiation data with the sur-
ival data (Table 1) showed that ADX, whether before or after BrdU
abeling, significantly enhanced the number of new neurons in the
entate gyrus (§ P0.034, † P0.009, ‡ P0.0001). ADX prior to BrdU
dministration gave a higher number of new neurons than ADX after
rdU administration 28 days later (§ P0.034).ORT: P0.021). nxperiment 4: effect of removal of endogenous
lucocorticoids by ADX on neuronal differentiation
rdU/DCX/GFAP-stained brain sections at day 7 from the
hree treatment groups were analyzed and the percent-
ges of BrdU-stained cells immuno-positive for DCX,
FAP or neither are shown in Fig. 4b. One-way ANOVA
howed that there was no difference between the three
reatment groups in the percentages of BrdU-positive cells
lso positive for DCX, GFAP or neither (DCX: F2,230.053,
0.95; GFAP: F2,232.00, P0.16; Neither: F2,230.46,
0.64). Sections from the day 28 survival groups were
tained for BrdU/NeuN/GFAP. One-way ANOVA of the
hree treatment groups (Fig. 4c) showed no difference in
he phenotypes of the BrdU-stained cells after treatment
NeuN: F2,231.21, P0.32; GFAP: F2,230.98, P0.40;
either: F2,232.97, P0.08). The number of new neurons
ormed in each group was estimated using both the survival
nd differentiation data, and are shown in Fig. 4d. One-way
NOVA and post hoc analysis showed that post-mitotic ADX
ignificantly increased the total number of new neurons
ormed in the dentate gyrus (Bonferroni; P0.025).
xperiment 5: effect of a corticoid-free environment
uring proliferation
henotypic analysis of the four day 28 survival groups
howed no difference in the phenotype of the BrdU-stained
ells between the four treatments (Fig. 5b, one-way ANOVA,
euN: F3,310.227, P0.88; GFAP: F3,311.32, P0.29;
either: F3,310.30, P0.82). Estimating the total number of
ew neurons formed using the survival and differentiation
ata revealed an interesting trend (Fig. 5c); two-way ANOVA
emonstrated that both pre-treatment and post-treatment
ere effective (Pre: F3,2331.6, P0.0001; Post:
3,2310.2, P0.003). There was no interaction between the
wo (F3,231.98, P0.171). One-way ANOVA and post hoc
nalysis demonstrated that all non-corticosterone-replaced
roups, either before or after BrdU, had higher numbers of
ew neurons 28 days after BrdU (CORT/Chol: § P0.034;
hol/CORT: †P0.009; Chol/Chol: ‡P0.0001). A corticoid-
ree environment before BrdU labeling generated more neu-
ons than a corticoid-free environment after BrdU labeling
Chol/CORT vs CORT/Chol: P0.034).
DISCUSSION
evelopment of progenitors in the dentate gyrus can be
ivided into three distinct stages: proliferation, survival and
ifferentiation. The effect of glucocorticoids, especially that of
orticosterone, on the first two stages has been demon-
trated previously (Gould et al., 1992; Cameron and Gould,
994; Wong and Herbert, 2004). In this report, we provide
ndings that fill a missing and crucial part of the developmen-
al trajectory of progenitor cells residing in the dentate gyrus.
sing fluorescence immunochemistry and cell-type specific
arkers, we show that corticosterone regulates the pheno-
ype of the newly-formed cells in the dentate gyrus.
Experiment 1 showed that in addition to its depressive
ction on proliferation and survival, corticosterone given dur-
ng the post-mitotic interval also reduces differentiation of the
ewly-formed cells into mature neurons. This could be dem-
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E. Y. H. Wong and J. Herbert / Neuroscience 137 (2006) 83–9290nstrated both at the day-7 and day-28 time points, at which
ime immature (DCX) and mature (NeuN) neuronal markers
espectively are maximally expressed. The reduction in neu-
onal differentiation can be accounted for in two ways. Firstly,
orticosterone may halt the differentiation process of certain
opulations of newly-formed cells, and thus the proportion
fate) of BrdU-positive cells also positive for these neuronal
arkers will be lower at any given time after BrdU labeling.
econdly, corticosterone may slow down the differentiation
rocess, thereby introducing a ‘differentiation lag’ in this pro-
ess. To clarify this, sections from the day-28 time point were
riple-stained for the immature neuronal marker DCX be-
ause only a small proportion of newly-formed cells would be
xpected to express this marker at day-28 (Brown et al.,
003). If the observed reduction in neuronal differentiation
fter corticosterone was a consequence of a time window
hift, one would expect to find a higher percentage of BrdU/
CX cells at the day-28 time point. However, our data sug-
ested that this was not the case. Therefore, it is likely that
orticosteronemay convey a ‘stop’ signal to the differentiation
rocess of the newly-formed cells, thus resulting in a decline
n neuronal differentiation. Combining the survival data from
ur previous report (Wong and Herbert, 2004) with the differ-
ntiation data we present here, high levels of corticosterone
resent after progenitor division significantly lowered the
umber of new neurons formed in the samples we took of the
entate gyrus of the hippocampus. Since we have no data on
ates of degeneration, it is also possible that increased apo-
tosis of maturing cells may contribute to the effects we
escribe here. A proportion of BrdU-labeled cells stained
able 1. The number of new neurons in the dentate gyrus after
AbN0%Sur%Diff where NAbabsolute number of new neurons,
ercentage surviving BrdU cells (data extracted from Wong and Herb
xperiment Group N0
Oil 2187.6154
High CORT 2187.6154
Oil 2187.6154
1 2187.6154
2 2187.6154
3 2187.6154
12 2187.6154
23 2187.6154
123 2187.6154
Oil/Oil 301594
Oil/CORT 301294
CORT/Oil 99679
CORT/CORT 99679
Sham 2192251
ADX 2192251
ADX Repld 2192251
CORT/CORT 2478265
CORT/Chol 2478265
Chol/CORT 7975804
Chol/Chol 7975804
Note that the total number of new neurons presented in this table
nimals and substituting into the equation, and therefore these values
ean percentages from each group.either for GFAP, NeuN or DCX. The identity of these cells memains unknown, but the most likely explanation is that they
re undifferentiated progenitor cells.
The regulation by corticosterone can be both direct
through receptors) and indirect, and candidates that me-
iate the effect of corticosterone include insulin-like growth
actor-1 (IGF-1), brain-derived neurotrophin factor (BDNF),
nd epidermal growth factor (EGF), all of which have been
hown to positively regulate adult neurogenesis and differ-
ntiation of progenitor cells (Kuhn et al., 1997; Aberg et al.,
000; Lee et al., 2002). Glucocorticoids may alter neuronal
ifferentiation via suppression of these pathways since
lucocorticoids negatively modulate the expression of
hese signaling molecules and their receptors (Islam et al.,
998; Schaaf et al., 2000; Gubba et al., 2004). The mech-
nism by which corticosterone regulates neuronal differ-
ntiation remains to be investigated.
There was an interesting difference between time-de-
endent actions of corticosterone on survival or differenti-
tion of new cells. We showed previously that excess corti-
osterone given for 9 days during the first 18 days reduced
urvival, whereas treatment during the final 9 days did not.
n contrast, this treatment regimen had no effect on the
evelopment of a neuronal phenotype, whereas corticoste-
one given during the final 9 days of the 28 day survival
nterval was effective. This suggests that there is a distinc-
ion between the corticoid-responsive processes regulat-
ng the two events, though the exact nature of either is still
o be uncovered. Raised corticosterone, it seems, exerts
aximal effect on survival during the early stages of pro-
enitor development while its effect on differentiation is
rimental treatments described in the text. This was estimated by
ber of cells labelled by BrdU 24 hours after labelling, %Surmean
) and %Diffpercentage of BrdU immuno-positive NeuN.
Mean %Sur Mean %Diff Total new neurons
50.35.0 67.92.1 712.065.0
34.43.8 47.33.1 403.542.6
72.67.3 69.52.1 1111125
58.310.3 65.93.0 101072.1
69.914.5 62.72.8 953108
84.14.9 59.93.1 1019105
46.02.0 58.92.7 59851.3
53.82.3 56.63.0 65726.1
48.63.4 48.42.3 513.942.7
51.02.4 62.33.2 104787
29.11.2 31.63.0 27327
26.84.1 47.83.8 12033
11.52.5 24.54.1 39.313.7
45.51.4 64.22.8 62628.9
70.04.7 58.13.0 88085.1
41.22.8 64.95.0 56042.1
31.13.2 64.65.0 60682.8
48.32.9 71.34.2 84461
20.71.5 68.96.6 1167155
31.13.5 72.22.2 1779191
culated from taking the corresponding %sur and %diff from individual
necessarily be the same as those obtained by simply multiplying thethe expe
N0num
ert, 2004
were cal
may notost powerful at a later stage. Combining the differentia-
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E. Y. H. Wong and J. Herbert / Neuroscience 137 (2006) 83–92 91ion and survival data (Wong and Herbert, 2004) revealed
hat none of the 9-day treatment groups significantly re-
uced the total number of new neurons produced, but
nimals receiving corticosterone for 18 days or more re-
ulted in significantly fewer neurons being produced.
High levels of corticosterone present prior to BrdU
dministration also reduced subsequent neuronal differen-
iation, as shown by experiment 3. Corticosterone treat-
ent during the post-mitotic period in the experiment also
educed neuronal differentiation, confirming the results of
he previous experiments. Interestingly, treating animals
ith corticosterone before progenitor proliferation also re-
uced the proportion of BrdU cells expressing the mature
euronal marker 28 days after labeling, irrespective of the
reatment during the post-mitotic period. However, it is
oteworthy that the suppressive effect of corticosterone on
ifferentiation is stronger during the post-mitotic period.
hese actions are likely to be direct, since newly-formed
ells express corticoid receptors at birth and the expres-
ion of these receptors increases over time (Garcia et al.,
004). However, any effect by glucocorticoids prior to pro-
enitor division and during the early stages of development
f these cells (when receptor expression is still low) are
ikely to be mediated by the surrounding local environment.
oward the day 28 time point, more differentiated cells
ay express corticoid receptors, so that the fact that post-
itotic corticosterone had a more prominent effect is pos-
ibly due to the increased sensitivity of more mature newly-
ormed cells to corticosterone from 19 to 27 days after
irth. Nonetheless, estimation of total neuron production
evealed that corticosterone treatment before progenitor
ivision resulted in fewer neurons compared with animals
eceiving corticosterone during the post-mitotic period
nly. Combining the two treatments showed that neuron
roduction in animals receiving corticosterone in both pe-
iods was merely 3.7% that of the control group.
Thus far, data in the literature and this report suggest
hat raised corticosterone is detrimental to all three stages
f neurogenesis, proliferation, survival and differentiation,
nd that raised corticosterone reduces the number of neu-
ons produced consequentially. Removal of glucocorticoids
y ADX, on the other hand, positively regulates prolifera-
ion and survival of the progenitor cells (Wong and Herbert,
004). However, triple staining in this report showed that
DX, and thus a relatively corticoid-free environment, did
ot favor increased proportional differentiation of newly-
ormed cells into neurons (experiments 4 and 5). Nonethe-
ess, a corticoid-free environment during the post-mitotic
eriod resulted in high number of neurons since overall
urvival is increased. Removal of glucocorticoids during
oth periods resulted in a 92.7% increase in the total
umber of new neurons in the sampled region relative to
he control group. Although there is no evidence thus far to
emonstrate that daily fluctuation of plasma corticoid lev-
ls would affect neurogenesis, it is important to note that
igh levels of glucocorticoids, as a result of physical or
sychological stress, may have serious consequences on
eurogenesis in the hippocampus. The dose of additional
orticosterone we used (40 mg/kg/day) is supra-physiolog-cal, and well into the ‘stress’ range. Ageing is also accom-
anied by raised circulating glucocorticoids (Sapolsky, 1992;
upien et al., 1994) and it has been shown that hippocampal
eurogenesis is reduced at old age, but data also exist to
upport manipulation of corticoid (by ADX) could reverse this
uppression (Cameron and McKay, 1999).
A large body of literature suggests that excess cortico-
terone is detrimental to hippocampal functions such as
orking and spatial memories (Coburn-Litvak et al., 2003;
oodson et al., 2003). If new neurons in the adult hippo-
ampus are indeed responsible for the formation of new
emory (Shors et al., 2001), the reduction after cortico-
terone may account for the behavioral deficits observed in
he learning models. Nonetheless, it is of immense interest
o investigate whether a change in the number of new neu-
ons in the dentate gyrus predicts a decline in hippocampal
unction, since new neurons numbers may be associated
ith synaptic changes and other molecular events such as
TP and LDP. Removal of glucocorticoids by ADX also im-
airs hippocampal-dependent learning (Armstrong et al.,
993; Vaher et al., 1994) and this is reversed by corticoste-
one replacement (Sousa et al., 1999). Moreover, ADX
auses dramatic cell death in the granule cell layer (Cameron
nd Gould, 1996). Our observed increase in neuronal pro-
uction in ADX animals may serve to compensate for this
xtensive loss. Whether the rate of ADX-induced cell loss is
reater than the accompanying increase in new neuronal
roduction, such that a net loss of granular neurons accounts
or the decline in function, awaits further study.
The finding that glucocorticoids regulate neuronal dif-
erentiation in the dentate gyrus of the adult rat has impor-
ant implications for those interested in the effects of stress
n brain structure and function. This also provides further
upport for the recent suggestions that adult neurogenesis
ay be concerned with the psychopathology of major de-
ressive disorder, a condition in which elevated glucocor-
icoids have been associated both as a risk factor for this
ondition, as well as one manifestation of the disease
rocess itself (Goodyer et al., 2000; Harris et al., 2000;
uman, 2004; Sapolsky, 2004).
cknowledgments—This work was supported by a grant from the
ellcome Trust. Edmund Y. H. Wong received a scholarship from
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